14-day Premium Trial Subscription Sign Up For FreeGet Free

Weaker Stock
Today ADAP ranks #11063 as sell candidate. Get a Free Stock at Robinhood
Stronger Stock

Adaptimmune Therapeutics plc Stock Forecast NASDAQ:ADAP

$5.21 (-1.14%)

Volume: 527k

Closed: Oct 22, 2021

Hollow Logo Score: -1.813

Adaptimmune Therapeutics plc Stock Forecast

$5.21 (-1.14%)

Volume: 527k

Closed: Oct 22, 2021

Score Hollow Logo -1.813

Adaptimmune Therapeutics plc Stock Price (Quote) NASDAQ:ADAP

$5.21 ( -1.14% ) Friday, 22nd Oct 2021

Range Low Price High Price Comment
30 days $5.04 $5.94 Friday, 22nd Oct 2021 ADAP stock ended at $5.21. This is 1.14% less than the trading day before Thursday, 21st Oct 2021. During the day the stock fluctuated 2.34% from a day low at $5.13 to a day high of $5.25.
90 days $3.37 $6.86
52 weeks $3.37 $7.34

Historical Adaptimmune Therapeutics plc prices

Date Open High Low Close Volume
2021-10-22 $5.24 $5.25 $5.13 $5.21 527 353
2021-10-21 $5.20 $5.33 $5.17 $5.27 369 943
2021-10-20 $5.29 $5.33 $5.16 $5.20 406 037
2021-10-19 $5.24 $5.39 $5.21 $5.27 636 093
2021-10-18 $5.35 $5.38 $5.20 $5.23 433 433
2021-10-15 $5.50 $5.50 $5.25 $5.33 576 276
2021-10-14 $5.48 $5.55 $5.34 $5.45 524 108
2021-10-13 $5.39 $5.67 $5.35 $5.44 845 254
2021-10-12 $5.19 $5.38 $5.19 $5.35 544 268
2021-10-11 $5.15 $5.28 $5.04 $5.18 451 657
2021-10-08 $5.17 $5.24 $5.04 $5.12 613 774
2021-10-07 $5.17 $5.25 $5.09 $5.16 198 188
2021-10-06 $5.10 $5.29 $5.04 $5.09 490 531
2021-10-05 $5.19 $5.31 $5.10 $5.19 526 684
2021-10-04 $5.32 $5.34 $5.08 $5.18 604 495
2021-10-01 $5.25 $5.46 $5.15 $5.39 886 145
2021-09-30 $5.20 $5.32 $5.15 $5.17 672 139
2021-09-29 $5.53 $5.65 $5.18 $5.20 1 259 978
2021-09-28 $5.73 $5.77 $5.38 $5.43 1 274 948
2021-09-27 $5.75 $5.94 $5.68 $5.82 880 623
2021-09-24 $5.65 $5.82 $5.64 $5.76 800 094
2021-09-23 $5.79 $5.90 $5.58 $5.76 914 383
2021-09-22 $5.51 $5.82 $5.50 $5.75 1 654 649
2021-09-21 $5.12 $5.60 $5.11 $5.50 2 140 223
2021-09-20 $5.20 $5.35 $5.03 $5.08 1 098 222
2021-09-17 $5.23 $5.43 $5.16 $5.40 1 894 091
2021-09-16 $5.41 $5.41 $5.07 $5.29 2 506 868
2021-09-15 $5.35 $5.50 $5.33 $5.40 1 201 999
2021-09-14 $5.81 $5.94 $5.25 $5.31 3 913 489
2021-09-13 $6.82 $6.84 $5.75 $5.85 6 648 233
2021-09-10 $6.43 $6.86 $6.12 $6.25 3 344 762
2021-09-09 $6.20 $6.65 $6.06 $6.21 2 612 014
2021-09-08 $6.20 $6.55 $6.00 $6.25 6 292 611
2021-09-07 $6.10 $6.82 $5.59 $6.37 46 455 484
2021-09-03 $4.95 $5.12 $4.90 $4.94 1 341 945
2021-09-02 $5.05 $5.09 $4.92 $4.94 1 117 077
2021-09-01 $5.14 $5.25 $4.96 $5.05 1 213 141
2021-08-31 $5.21 $5.33 $5.14 $5.17 966 581
2021-08-30 $5.26 $5.42 $4.96 $5.24 1 673 296
2021-08-27 $5.03 $5.23 $4.88 $5.15 1 217 090
2021-08-26 $4.90 $5.42 $4.85 $5.05 1 917 207
2021-08-25 $4.38 $5.19 $4.31 $4.95 3 003 626
2021-08-24 $4.32 $4.49 $4.20 $4.38 890 049
2021-08-23 $3.99 $4.32 $3.93 $4.28 1 138 819
2021-08-20 $3.75 $3.82 $3.67 $3.80 375 930
2021-08-19 $3.87 $3.96 $3.75 $3.76 568 263
2021-08-18 $3.82 $4.01 $3.77 $3.95 615 345
2021-08-17 $3.95 $3.95 $3.73 $3.87 817 290
2021-08-16 $3.95 $4.02 $3.85 $3.95 1 141 397
2021-08-13 $3.84 $4.08 $3.75 $3.99 1 020 204

About Adaptimmune Therapeutics plc

Adaptimmune Therapeutics plc Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on the provision of cancer immunotherapy products based on its T-cell receptor platform. Its platform enables to identify cancer targets; find and genetically engineer T-cell receptors (TCR); and produce TCR therapeutic candidates for administration to patients. The company’s lead program includes NY-ESO cancer antigen, which is in Phase 1/2 clinical trials for the... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT